Obama fingers FDA as agency in need of overhaul

Will the FDA get an Obama-backed makeover? Before a panel meeting on jobs and competitiveness, the president said the FDA isn't up to speed on current technology, so it's not able and ready to handle current medical advances, the Financial Times reports.

The White House is in the midst of a push to bolster the economy, and President Obama has promised to review government regulation as part of that effort. At the panel meeting, Obama emphasized that regulations protecting safety should stick around, but redundant rules and unnecessary red tape should go. The industry lobby PhRMA has complained of "an overdose of regulations that imperils the future growth" of the industry.

As the FT reports, Obama highlighted the FDA as an agency that should be modernized. "I've gotten a lot of commentary about the fact that ... essentially their model was designed for the kind of medical devices you see in museums," the president said. "So that would be an area where [we should be] getting a group to think strategically about how ... [we design] these regulatory bodies so that they are up to speed and more responsive to a dynamic economy," he added.

- read the FT story

Suggested Articles

Novartis is rolling out positive interim phase 3 data on Zolgensma in Europe, which could support the recent launch of the SMA gene therapy there.

The new cost-cutting goal comes on top of a €2.6 billion annual savings target the company already laid out in a revamp initiated in 2018.

As hearings continued on Capitol Hill, a congressional committee said Novartis, Amgen and Mallinckrodt used routine price hikes to meet sales targets.